Logo image of MHUA

MEIHUA INTL MEDICAL- CLASS A (MHUA) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MHUA - KYG5966G1082 - Common Stock

7.61 USD
-6.41 (-45.72%)
Last: 12/8/2025, 8:26:08 PM
6.11 USD
-1.5 (-19.71%)
After Hours: 12/8/2025, 8:26:08 PM
Fundamental Rating

5

MHUA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. MHUA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. MHUA has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

MHUA had positive earnings in the past year.
MHUA had a positive operating cash flow in the past year.
Each year in the past 5 years MHUA has been profitable.
The reported operating cash flow has been mixed in the past 5 years: MHUA reported negative operating cash flow in multiple years.
MHUA Yearly Net Income VS EBIT VS OCF VS FCFMHUA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

MHUA's Return On Assets of 7.34% is amongst the best of the industry. MHUA outperforms 88.24% of its industry peers.
With an excellent Return On Equity value of 8.48%, MHUA belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
MHUA has a Return On Invested Capital of 7.79%. This is amongst the best in the industry. MHUA outperforms 83.96% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MHUA is below the industry average of 8.82%.
The 3 year average ROIC (6.66%) for MHUA is below the current ROIC(7.79%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.34%
ROE 8.48%
ROIC 7.79%
ROA(3y)5.46%
ROA(5y)9.91%
ROE(3y)6.42%
ROE(5y)12.22%
ROIC(3y)6.66%
ROIC(5y)11.82%
MHUA Yearly ROA, ROE, ROICMHUA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

MHUA has a better Profit Margin (10.37%) than 84.49% of its industry peers.
In the last couple of years the Profit Margin of MHUA has declined.
With an excellent Operating Margin value of 13.01%, MHUA belongs to the best of the industry, outperforming 80.75% of the companies in the same industry.
MHUA's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 34.04%, MHUA is doing worse than 74.87% of the companies in the same industry.
MHUA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 13.01%
PM (TTM) 10.37%
GM 34.04%
OM growth 3Y-16.41%
OM growth 5Y-9.53%
PM growth 3Y-17.73%
PM growth 5Y-10.37%
GM growth 3Y-3.53%
GM growth 5Y-3.21%
MHUA Yearly Profit, Operating, Gross MarginsMHUA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MHUA is still creating some value.
The number of shares outstanding for MHUA has been increased compared to 1 year ago.
The number of shares outstanding for MHUA has been increased compared to 5 years ago.
The debt/assets ratio for MHUA has remained at the same level compared to a year ago.
MHUA Yearly Shares OutstandingMHUA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MHUA Yearly Total Debt VS Total AssetsMHUA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 2.79 indicates that MHUA is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.79, MHUA is in the better half of the industry, outperforming 69.52% of the companies in the same industry.
MHUA has a debt to FCF ratio of 3.19. This is a good value and a sign of high solvency as MHUA would need 3.19 years to pay back of all of its debts.
MHUA's Debt to FCF ratio of 3.19 is amongst the best of the industry. MHUA outperforms 82.89% of its industry peers.
A Debt/Equity ratio of 0.07 indicates that MHUA is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.07, MHUA is in the better half of the industry, outperforming 66.84% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 3.19
Altman-Z 2.79
ROIC/WACC1.68
WACC4.63%
MHUA Yearly LT Debt VS Equity VS FCFMHUA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 5.71 indicates that MHUA has no problem at all paying its short term obligations.
MHUA has a better Current ratio (5.71) than 81.28% of its industry peers.
A Quick Ratio of 5.66 indicates that MHUA has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 5.66, MHUA belongs to the top of the industry, outperforming 83.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.71
Quick Ratio 5.66
MHUA Yearly Current Assets VS Current LiabilitesMHUA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M

1

3. Growth

3.1 Past

The earnings per share for MHUA have decreased strongly by -22.59% in the last year.
MHUA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -13.75% yearly.
The Revenue has decreased by -5.30% in the past year.
Measured over the past years, MHUA shows a small growth in Revenue. The Revenue has been growing by 4.01% on average per year.
EPS 1Y (TTM)-22.59%
EPS 3Y-27.74%
EPS 5Y-13.75%
EPS Q2Q%-35.81%
Revenue 1Y (TTM)-5.3%
Revenue growth 3Y-2.33%
Revenue growth 5Y4.01%
Sales Q2Q%-16.24%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MHUA Yearly Revenue VS EstimatesMHUA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.53 indicates a correct valuation of MHUA.
Based on the Price/Earnings ratio, MHUA is valued cheaply inside the industry as 87.17% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.57, MHUA is valued a bit cheaper.
Industry RankSector Rank
PE 15.53
Fwd PE N/A
MHUA Price Earnings VS Forward Price EarningsMHUA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than MHUA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.19
EV/EBITDA -0.62
MHUA Per share dataMHUA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

MHUA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

MHUA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

MEIHUA INTL MEDICAL- CLASS A

NASDAQ:MHUA (12/8/2025, 8:26:08 PM)

After market: 6.11 -1.5 (-19.71%)

7.61

-6.41 (-45.72%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-29 2022-11-29/bmo
Earnings (Next)N/A N/A
Inst Owners0.23%
Inst Owner Change-22.03%
Ins Owners28.5%
Ins Owner ChangeN/A
Market Cap4.26M
Revenue(TTM)134.89M
Net Income(TTM)13.99M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.53
Fwd PE N/A
P/S 0.03
P/FCF 1.19
P/OCF 1.15
P/B 0.03
P/tB 0.03
EV/EBITDA -0.62
EPS(TTM)0.49
EY6.44%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)6.4
FCFY84.13%
OCF(TTM)6.64
OCFY87.26%
SpS240.88
BVpS294.54
TBVpS293.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number56.99
Profitability
Industry RankSector Rank
ROA 7.34%
ROE 8.48%
ROCE 10.64%
ROIC 7.79%
ROICexc 8.54%
ROICexgc 8.57%
OM 13.01%
PM (TTM) 10.37%
GM 34.04%
FCFM 2.66%
ROA(3y)5.46%
ROA(5y)9.91%
ROE(3y)6.42%
ROE(5y)12.22%
ROIC(3y)6.66%
ROIC(5y)11.82%
ROICexc(3y)7.64%
ROICexc(5y)13.07%
ROICexgc(3y)7.74%
ROICexgc(5y)13.18%
ROCE(3y)8.91%
ROCE(5y)15.78%
ROICexgc growth 3Y-27.75%
ROICexgc growth 5Y-25.86%
ROICexc growth 3Y-27.69%
ROICexc growth 5Y-25.71%
OM growth 3Y-16.41%
OM growth 5Y-9.53%
PM growth 3Y-17.73%
PM growth 5Y-10.37%
GM growth 3Y-3.53%
GM growth 5Y-3.21%
F-Score5
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 3.19
Debt/EBITDA 0.63
Cap/Depr 24.05%
Cap/Sales 0.1%
Interest Coverage 69.48
Cash Conversion 20.54%
Profit Quality 25.63%
Current Ratio 5.71
Quick Ratio 5.66
Altman-Z 2.79
F-Score5
WACC4.63%
ROIC/WACC1.68
Cap/Depr(3y)500.62%
Cap/Depr(5y)471.13%
Cap/Sales(3y)2.53%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.59%
EPS 3Y-27.74%
EPS 5Y-13.75%
EPS Q2Q%-35.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.3%
Revenue growth 3Y-2.33%
Revenue growth 5Y4.01%
Sales Q2Q%-16.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-14.66%
EBIT growth 3Y-18.36%
EBIT growth 5Y-5.9%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y701.6%
FCF growth 3YN/A
FCF growth 5Y109.43%
OCF growth 1Y543.15%
OCF growth 3YN/A
OCF growth 5Y9.47%

MEIHUA INTL MEDICAL- CLASS A / MHUA FAQ

Can you provide the ChartMill fundamental rating for MEIHUA INTL MEDICAL- CLASS A?

ChartMill assigns a fundamental rating of 5 / 10 to MHUA.


Can you provide the valuation status for MEIHUA INTL MEDICAL- CLASS A?

ChartMill assigns a valuation rating of 4 / 10 to MEIHUA INTL MEDICAL- CLASS A (MHUA). This can be considered as Fairly Valued.


What is the profitability of MHUA stock?

MEIHUA INTL MEDICAL- CLASS A (MHUA) has a profitability rating of 6 / 10.


What are the PE and PB ratios of MEIHUA INTL MEDICAL- CLASS A (MHUA) stock?

The Price/Earnings (PE) ratio for MEIHUA INTL MEDICAL- CLASS A (MHUA) is 15.53 and the Price/Book (PB) ratio is 0.03.